NIH-funded research R01 grant

How fetal blood cells develop and what it means for immune health

Official title: The developmental pathway of fetal-derived B cells

Funded at Western Michigan Univ School of Medicine · NIH-11352523 · Data updated 2026-11-12

A study from Western Michigan University investigates how a special type of immune cells called B cells develop before birth and how they continue to function later in life.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWestern Michigan Univ School of Medicine
NIH-funded
Lab location1 site (Kalamazoo, United States)
Project startDecember 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$602,484
NIH project number5R01AI165798-05
Project IDNIH-11352523 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with autoimmune conditions or B-cell related disorders, or healthy adults providing samples for comparative analyses.

Less likely to help

Individuals without autoimmune or B-cell related conditions may participate but may not directly benefit.

What this research studies

This project explores whether some B cells can arise from embryonic endothelial cells rather than from traditional stem cells, and how these cells persist as we age. Researchers will examine the developmental pathways of B-2 cells and compare their behavior to B cells derived from hematopoietic stem cells. By using models and analyses focused on human biology, the work aims to clarify how these fetal-origin B cells contribute to infections, autoimmunity, and immune health. The findings could reshape our understanding of immune development and potentially influence future therapies for immune-related diseases.

Why it matters

Potential benefit: Better knowledge of how B cells develop could lead to new approaches for preventing or treating autoimmune diseases and improving immune responses.

How similar studies have gone: Previous work suggests that some fetal-origin B cells persist into adulthood, but the exact pathways and implications remain largely unexplored.

Where this research is happening

  • Western Michigan Univ School of Medicine
    Kalamazoo, United States
    Active

Researchers

  • Principal investigator: Yoshimoto, Momoko — Western Michigan Univ School of Medicine
  • Study coordinator: Yoshimoto, Momoko

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.